STRATA Common Stock Total Equity vs Other Current Assets Analysis

SSKN Stock

USD 3.10 0.25 7.46%

STRATA Skin financial indicator trend analysis is much more than just breaking down STRATA Skin Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STRATA Skin Sciences is a good investment. Please check the relationship between STRATA Skin Common Stock Total Equity and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Common Stock Total Equity vs Other Current Assets

Common Stock Total Equity vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STRATA Skin Sciences Common Stock Total Equity account and Other Current Assets. At this time, the significance of the direction appears to have weak relationship.

The correlation between STRATA Skin's Common Stock Total Equity and Other Current Assets is 0.36. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of STRATA Skin Sciences, assuming nothing else is changed. The correlation between historical values of STRATA Skin's Common Stock Total Equity and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of STRATA Skin Sciences are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Common Stock Total Equity i.e., STRATA Skin's Common Stock Total Equity and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.36

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from STRATA Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STRATA Skin Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

As of the 15th of November 2024, Selling General Administrative is likely to drop to about 8.9 M. In addition to that, Tax Provision is likely to grow to about (87.4 K)

STRATA Skin fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Non Current Assets Total	Common Stock Shares Outstanding	Total Current Assets	Other Stockholder Equity	Non Currrent Assets Other	Other Current Assets	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Net Debt	Cash	Cash And Short Term Investments	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Other Assets	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Preferred Stock Total Equity
Total Assets		0.73	-0.77	0.86	0.42	0.52	0.83	0.15	0.31	0.73	0.58	0.33	0.72	0.27	0.21	0.2	0.57	0.61	0.69	0.13	0.9	0.18	0.5	0.31	0.21	-0.57
Total Stockholder Equity	0.73		-0.57	0.39	0.59	0.85	0.68	0.09	0.26	0.16	0.09	0.4	0.45	-0.37	0.73	0.73	0.1	0.51	0.33	0.4	0.44	0.34	-0.16	0.05	-0.07	-0.65
Retained Earnings	-0.77	-0.57		-0.76	-0.28	-0.37	-0.92	0.03	-0.26	-0.69	-0.58	-0.39	-0.68	-0.37	-0.06	-0.06	-0.68	-0.54	-0.6	-0.13	-0.76	-0.29	-0.3	-0.61	-0.47	0.83
Non Current Assets Total	0.86	0.39	-0.76		0.25	0.09	0.67	0.06	0.15	0.93	0.74	0.23	0.6	0.67	-0.22	-0.22	0.83	0.5	0.79	-0.21	0.95	-0.03	0.74	0.36	0.46	-0.42
Common Stock Shares Outstanding	0.42	0.59	-0.28	0.25		0.42	0.41	0.01	-0.13	0.04	-0.1	0.57	0.19	-0.22	0.37	0.37	-0.07	0.39	0.35	0.06	0.36	0.15	-0.06	0.0	-0.09	-0.17
Total Current Assets	0.52	0.85	-0.37	0.09	0.42		0.45	0.21	0.39	0.02	-0.08	0.26	0.39	-0.56	0.88	0.88	-0.1	0.51	0.01	0.69	0.21	0.43	-0.31	0.02	-0.03	-0.51
Other Stockholder Equity	0.83	0.68	-0.92	0.67	0.41	0.45		0.0	0.26	0.51	0.48	0.47	0.69	0.18	0.16	0.16	0.47	0.49	0.61	0.17	0.73	0.31	0.22	0.54	0.16	-0.82
Non Currrent Assets Other	0.15	0.09	0.03	0.06	0.01	0.21	0.0		-0.17	0.11	0.2	-0.52	-0.23	-0.03	0.23	0.23	0.09	-0.26	0.26	0.25	0.0	-0.32	0.3	0.07	-0.05	-0.1
Other Current Assets	0.31	0.26	-0.26	0.15	-0.13	0.39	0.26	-0.17		0.2	0.06	0.04	0.74	0.02	0.05	0.05	0.08	0.41	-0.01	0.69	0.22	0.36	-0.19	0.15	0.03	-0.18
Total Liab	0.73	0.16	-0.69	0.93	0.04	0.02	0.51	0.11	0.2		0.78	0.09	0.57	0.77	-0.31	-0.31	0.87	0.48	0.66	-0.15	0.88	-0.03	0.81	0.43	0.64	-0.32
Short Long Term Debt Total	0.58	0.09	-0.58	0.74	-0.1	-0.08	0.48	0.2	0.06	0.78		-0.09	0.28	0.76	-0.26	-0.26	0.8	-0.01	0.64	-0.17	0.64	-0.15	0.76	0.24	0.48	-0.44
Other Current Liab	0.33	0.4	-0.39	0.23	0.57	0.26	0.47	-0.52	0.04	0.09	-0.09		0.41	-0.08	0.11	0.11	-0.07	0.49	-0.03	-0.12	0.34	0.41	-0.13	0.33	-0.06	-0.23
Total Current Liabilities	0.72	0.45	-0.68	0.6	0.19	0.39	0.69	-0.23	0.74	0.57	0.28	0.41		0.25	-0.04	-0.04	0.41	0.79	0.38	0.34	0.72	0.45	0.15	0.42	0.23	-0.39
Net Debt	0.27	-0.37	-0.37	0.67	-0.22	-0.56	0.18	-0.03	0.02	0.77	0.76	-0.08	0.25		-0.78	-0.77	0.74	0.0	0.53	-0.4	0.55	-0.36	0.8	0.35	0.5	0.0
Cash	0.21	0.73	-0.06	-0.22	0.37	0.88	0.16	0.23	0.05	-0.31	-0.26	0.11	-0.04	-0.78		1.0	-0.31	0.21	-0.2	0.53	-0.13	0.32	-0.47	-0.29	-0.15	-0.36
Cash And Short Term Investments	0.2	0.73	-0.06	-0.22	0.37	0.88	0.16	0.23	0.05	-0.31	-0.26	0.11	-0.04	-0.77	1.0		-0.31	0.21	-0.2	0.53	-0.13	0.32	-0.47	-0.29	-0.14	-0.36
Property Plant And Equipment Net	0.57	0.1	-0.68	0.83	-0.07	-0.1	0.47	0.09	0.08	0.87	0.8	-0.07	0.41	0.74	-0.31	-0.31		0.3	0.63	-0.28	0.73	0.06	0.68	0.26	0.78	-0.46
Current Deferred Revenue	0.61	0.51	-0.54	0.5	0.39	0.51	0.49	-0.26	0.41	0.48	-0.01	0.49	0.79	0.0	0.21	0.21	0.3		0.19	0.2	0.65	0.52	0.05	0.26	0.33	-0.26
Accounts Payable	0.69	0.33	-0.6	0.79	0.35	0.01	0.61	0.26	-0.01	0.66	0.64	-0.03	0.38	0.53	-0.2	-0.2	0.63	0.19		-0.2	0.73	-0.12	0.62	0.3	0.23	-0.38
Other Assets	0.13	0.4	-0.13	-0.21	0.06	0.69	0.17	0.25	0.69	-0.15	-0.17	-0.12	0.34	-0.4	0.53	0.53	-0.28	0.2	-0.2		-0.11	0.15	-0.44	0.07	-0.15	-0.24
Net Receivables	0.9	0.44	-0.76	0.95	0.36	0.21	0.73	0.0	0.22	0.88	0.64	0.34	0.72	0.55	-0.13	-0.13	0.73	0.65	0.73	-0.11		0.09	0.68	0.34	0.46	-0.38
Common Stock Total Equity	0.18	0.34	-0.29	-0.03	0.15	0.43	0.31	-0.32	0.36	-0.03	-0.15	0.41	0.45	-0.36	0.32	0.32	0.06	0.52	-0.12	0.15	0.09		-0.37	0.18	0.15	-0.44
Non Current Liabilities Total	0.5	-0.16	-0.3	0.74	-0.06	-0.31	0.22	0.3	-0.19	0.81	0.76	-0.13	0.15	0.8	-0.47	-0.47	0.68	0.05	0.62	-0.44	0.68	-0.37		0.22	0.38	0.01
Inventory	0.31	0.05	-0.61	0.36	0.0	0.02	0.54	0.07	0.15	0.43	0.24	0.33	0.42	0.35	-0.29	-0.29	0.26	0.26	0.3	0.07	0.34	0.18	0.22		0.09	-0.47
Property Plant And Equipment Gross	0.21	-0.07	-0.47	0.46	-0.09	-0.03	0.16	-0.05	0.03	0.64	0.48	-0.06	0.23	0.5	-0.15	-0.14	0.78	0.33	0.23	-0.15	0.46	0.15	0.38	0.09		-0.24
Preferred Stock Total Equity	-0.57	-0.65	0.83	-0.42	-0.17	-0.51	-0.82	-0.1	-0.18	-0.32	-0.44	-0.23	-0.39	0.0	-0.36	-0.36	-0.46	-0.26	-0.38	-0.24	-0.38	-0.44	0.01	-0.47	-0.24

Click cells to compare fundamentals

STRATA Skin Account Relationship Matchups

STRATA Skin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	27.2M	3.4M	3.4M	3.5M	3.5M	4.0M
Other Current Liab	4.5M	1.6M	2.4M	2.5M	1.7M	1.4M
Accounts Payable	1.8M	2.8M	2.8M	3.4M	3.3M	2.5M
Other Assets	428K	347K	1.3M	216K	248.4K	301.5K
Property Plant Equipment	5.3M	5.4M	6.5M	7.5M	8.6M	4.7M
Other Liab	499K	178K	288K	666K	765.9K	1.1M
Net Tangible Assets	12.7M	11.9M	10.7M	6.5M	5.9M	6.7M
Retained Earnings Total Equity	(229.4M)	(210.8M)	(214.6M)	(219.0M)	(197.1M)	(206.9M)
Capital Surpluse	251.6M	242.0M	243.2M	244.8M	281.6M	235.9M

Pair Trading with STRATA Skin

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.

Moving against STRATA Stock

0.59	DRIO	DarioHealth Corp	Pair Corr
0.54	CVS	CVS Health Corp	Pair Corr
0.45	AHG	Akso Health Group	Pair Corr

The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.

The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:

How To Invest In STRATA

Details

Is STRATA Stock a good investment?

Details

What is STRATA Skin's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.37)

Revenue Per Share

9.347

Quarterly Revenue Growth

0.022

Return On Assets

(0.07)

Return On Equity

(0.63)

The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

STRATA Common Stock Total Equity vs Other Current Assets Analysis

Common Stock Total Equity vs Other Current Assets

Common Stock Total Equity vs Other Current Assets Correlation Analysis

Correlation Coefficient

Common Stock Total Equity

Other Current Assets

STRATA Skin fundamental ratios Correlations

STRATA Skin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

STRATA Skin fundamental ratios Accounts

Pair Trading with STRATA Skin

Moving against STRATA Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Net Receivables	+ 0.95	Non Current Assets Total
Total Liab	+ 0.93	Non Current Assets Total
Net Receivables	+ 0.9	Total Assets
Cash	+ 0.88	Total Current Assets
Cash And Short Term Investments	+ 0.88	Total Current Assets

Other Stockholder Equity	- 0.92	Retained Earnings
Preferred Stock Total Equity	- 0.82	Other Stockholder Equity
Cash	- 0.78	Net Debt
Cash And Short Term Investments	- 0.77	Net Debt
Retained Earnings	- 0.77	Total Assets
Net Receivables	- 0.76	Retained Earnings